IDR 2600.0
(-1.52%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 308.5 Billion IDR | -31.17% |
2022 | 447.04 Billion IDR | -40.92% |
2021 | 756.62 Billion IDR | 150.73% |
2020 | 301.76 Billion IDR | 39.67% |
2019 | 216.04 Billion IDR | 20.08% |
2018 | 179.91 Billion IDR | 20.14% |
2017 | 149.75 Billion IDR | 15.55% |
2016 | 129.6 Billion IDR | 33.69% |
2015 | 96.94 Billion IDR | 6.75% |
2014 | 90.8 Billion IDR | -3.32% |
2013 | 93.92 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 41.43 Billion IDR | 34.83% |
2024 Q3 | 87.66 Billion IDR | 0.89% |
2024 Q2 | 86.88 Billion IDR | 109.68% |
2023 Q2 | 90.28 Billion IDR | 9.09% |
2023 Q1 | 82.76 Billion IDR | -30.47% |
2023 FY | 307.69 Billion IDR | -31.17% |
2023 Q4 | 30.73 Billion IDR | -70.57% |
2023 Q3 | 104.43 Billion IDR | 15.66% |
2022 Q2 | 63.47 Billion IDR | -49.34% |
2022 Q1 | 125.29 Billion IDR | -4.04% |
2022 FY | 447.04 Billion IDR | -40.92% |
2022 Q3 | 139.24 Billion IDR | 119.39% |
2022 Q4 | 119.02 Billion IDR | -14.52% |
2021 Q2 | 172.62 Billion IDR | -10.51% |
2021 Q3 | 260.52 Billion IDR | 50.92% |
2021 Q4 | 130.57 Billion IDR | -49.88% |
2021 FY | 756.62 Billion IDR | 150.73% |
2021 Q1 | 192.9 Billion IDR | 7.48% |
2020 Q4 | 179.48 Billion IDR | 12.77% |
2020 Q1 | 29.09 Billion IDR | -72.29% |
2020 Q2 | -65.97 Billion IDR | -326.74% |
2020 Q3 | 159.16 Billion IDR | 341.23% |
2020 FY | 301.76 Billion IDR | 39.67% |
2019 Q3 | 35.41 Billion IDR | 27.11% |
2019 Q4 | 105.01 Billion IDR | 196.54% |
2019 Q2 | 27.85 Billion IDR | -41.68% |
2019 Q1 | 47.76 Billion IDR | -41.03% |
2019 FY | 216.04 Billion IDR | 20.08% |
2018 Q4 | 80.99 Billion IDR | 72.42% |
2018 Q3 | 46.97 Billion IDR | 103.02% |
2018 Q2 | 23.13 Billion IDR | -19.68% |
2018 Q1 | 28.8 Billion IDR | -56.06% |
2018 FY | 179.91 Billion IDR | 20.14% |
2017 Q4 | 65.55 Billion IDR | 76.7% |
2017 FY | 149.75 Billion IDR | 15.55% |
2017 Q3 | 37.1 Billion IDR | 595.35% |
2017 Q2 | 5.33 Billion IDR | -87.22% |
2017 Q1 | 41.76 Billion IDR | -48.28% |
2016 Q1 | 34 Billion IDR | 214.72% |
2016 Q2 | 25.18 Billion IDR | -25.94% |
2016 Q3 | -10.33 Billion IDR | -141.04% |
2016 Q4 | 80.74 Billion IDR | 881.16% |
2016 FY | 129.6 Billion IDR | 33.69% |
2015 Q2 | 26.25 Billion IDR | 0.0% |
2015 Q4 | 10.8 Billion IDR | 0.0% |
2015 FY | 96.94 Billion IDR | 6.75% |
2015 Q1 | 26.25 Billion IDR | 0.0% |
2015 Q3 | 10.8 Billion IDR | -58.85% |
2014 FY | 90.8 Billion IDR | -3.32% |
2013 FY | 93.92 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Diagnos Laboratorium Utama Tbk | -15.15 Billion IDR | 2136.148% |